The Therapeutic Goods Administration (TGA) has approved Pfizer Australia and BioNTech SE’s XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) for individuals aged 5 and over. The decision follows evidence that this vaccine can better protect against symptomatic and severe COVID-19. The vaccine is free and available at pharmacies and general practices across Australia.
The Great Stay: Why Tech Talent Is Choosing Stability Over Salary
How mass layoffs and economic anxiety have upended the talent war, turning “job hugging” into the public sector’s greatest opportunity to fill open tech positions.
